cprx: the income statement

MyFinsight

CATALYST PHARMACEUTICALS, INC. (CPRX)

For the quarter ending 2025-06-30, CPRX made $146,563K in revenue. $52,156K in net income. Net profit margin of 35.59%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30
Total revenues	146,563	141,421	128,695
Selling, general and administrative	45,949	46,911	45,880
Research and development	4,358	3,887	3,284
Cost of sales	20,614	17,911	19,277
Amortization of intangible assets	9,344	9,345	9,345
Total operating costs and expenses	80,265	78,054	77,786
Operating income	66,298	63,367	50,909
Other income, net	2,995	7,919	6,296
Net income before income taxes	69,293	71,286	57,205
Income tax provision	17,185	14,549	13,321
Net income	52,108	56,737	43,884
Unrealized gain (loss) on available-for-sale securities, net of tax of (15), 0, 10 and 4, respectively	48	-81	-
Comprehensive income	52,156	56,656	43,884

Diluted weighted average common shares outstanding	127,543,284	126,957,982	125,407,279
Earnings per share, basic	0.43	0.47	0.37
Earnings per share, diluted	0.41	0.45	0.35
Weighted average number of shares outstanding, basic	122,163,212	121,472,468	118,931,153

Unit: Thousand (K) dollars (except for numbers of shares and EPS)